Cannasouth and Eqalis' $48.8m 'merger' plans

Cannasouth and Eqalis' $48.8m 'merger' plans
Mark Lucas says it eliminates cost duplication at both firms. (Image: NZME)
Staff reporters
Cannasouth dropped 5% to 28.5 cents after the medicinal cannabis firm said it would pay $48.8 million for Equalis Pharmaceuticals in an all-scrip deal. It would also seek to raise another $9m to fund the enlarged group's working capital.The NZ stock exchange listed firm, based in Waikato, said it would issue 147.9m new Cannasouth shares at an issue price of 33c, doubling the number of shares on issue, and describing the transaction as a 'merger of equals'.Bay of Plenty-based Eqalis, founded in 2019, brings on board its capacity...

More Health

Kiwibank director joins Evolution Healthcare as chair
News in Brief

Kiwibank director joins Evolution Healthcare as chair

Scott Pickering has been appointed chair of Evolution Healthcare and director of Fidelity Life.Evolution Healthcare is a private healthcare operator and Fidelity Life is New Zealand’s largest locally-owned life insurer.His position at Evolution Healthcare began on Monday and the...

Staff reporters 01 Jul 2024
Health and Safety Reform: Watch the road not the cones
Opinion

Jeff Sissons: Health and Safety Reform: Watch the road not the cones

This govt and the previous one have been starving the health and safety system of funding.

Jeff Sissons 19 Jun 2024
Why Americans eat a sunscreen ingredient in their pizza
Health

Why Americans eat a sunscreen ingredient in their pizza

Health concerns grow over titanium dioxide, but NZ and Australia believe it's safe.

Green Cross makes healthcare a primary objective
Opinion

Paul McBeth: Green Cross makes healthcare a primary objective

Group has the country's largest general practice enrolled patient base. 

Paul McBeth 11 Jun 2024